Harvard Medical School Beth Israel Deaconess Medical Center

Boston, Massachusetts 02215

1 studies enrolling now · 5 studies all time

What they study most

B-cell Non-Hodgkins Lymphoma (B-NHL), Chronic Kidney Disease, Glioblastoma Multiforme, Relapsed/Refractory Aggressive B-Cell Lymphoma, Sepsis-Induced Hypotension, Type 2 Diabetes Mellitus

Studies at this site

• A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas — Recruiting now
• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies — Completed
• A Study of REGN7544 for the Treatment in Adult Patients With Sepsis-Induced Hypotension — Completed
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients — Completed